Olga G. Serebryakova

Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease

Sofya V. Lushchekina, Natalia P. Boltneva, V. V. Grigoriev et al. · Scientific Reports · 2015 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Esterase profiles of organophosphorus compounds in vitro predict their behavior in vivo

Olga G. Serebryakova, Sofya V. Lushchekina, Rudy J. Richardson · Chemico-Biological Interactions · 2016 · 68 citations

Life Sciences, Biochemistry, Pharmacology +14

9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment

Sofya V. Lushchekina, Natalia P. Boltneva, Olga G. Serebryakova et al. · Bioorganic & Medicinal Chemistry · 2017 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors

Natalia P. Boltneva, Sofya V. Lushchekina, Olga G. Serebryakova et al. · Bioorganic & Medicinal Chemistry · 2016 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment

Sofya V. Lushchekina, N. V. Kovaleva, T. Yu. Astakhova et al. · Bioorganic Chemistry · 2021 · 48 citations

Medicine, Neuroscience, Pharmacology +14